Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

Clinical trial NCT01338987 · COMPLETED

Trial details

NCT number: NCT01338987
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia

Start date: 2011-04-19
Primary completion: 2017-12-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.